Keros Therapeutics, Inc.
KROS
$11.58
$0.110.96%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
SeekingAlpha
3/10/2025
-
Stock Options Channel
3/10/2025
-
ETF Channel
3/7/2025
-
Tickeron - Technical Analysis
3/7/2025
-
Tickeron - Stocks
3/5/2025
-
Zacks Investment Research
3/5/2025
-
Tickeron - Stocks
3/4/2025
-
Stock Options Channel
3/3/2025
-
MarketBeat
3/2/2025
-
TipRanks Financial Blog
2/28/2025
-
GuruFocus
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
GuruFocus
2/28/2025
-
Globe Newswire
2/28/2025
-
MarketBeat
2/28/2025
-
MarketBeat
2/28/2025
-
Simply Wall St
2/27/2025
-
MarketBeat
2/27/2025
-
Ticker Report
2/27/2025
-
Benzinga
2/26/2025
-
TipRanks Financial Blog
2/26/2025
-
GuruFocus
2/26/2025
-
Zolmax
2/26/2025
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 314 6297
Address
1050 Waltham Street
Lexington, MA 02421
Lexington, MA 02421
Country
Year Founded
Business Description
Sector
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the...
more
